Silyl phosphorus and nitrogen donor chelates for homogeneous ortho borylation catalysis.

Ghaffari B, Preshlock SM, Plattner DL, Staples RJ, Maligres PE, Krska SW, Maleczka RE Jr, Smith MR 3rd

Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IPSS.

Zeidan AM, Lee JW, Prebet T, Greenberg P, Sun Z, Juckett M, Smith MR, Paietta E, Gabrilove J, Erba HP, Katterling RP, Tallman MS, Gore SD

Pharmacological inhibition of myostatin and changes in lean body mass and lower extremity muscle size in patients receiving androgen deprivation therapy for prostate cancer.

Padhi D, Higano CS, Shore ND, Sieber P, Rasmussen E, Smith MR

Molecular subtype classification of formalin-fixed, paraffin-embedded diffuse large B-cell lymphoma samples on the ICEPlex® system.

Collie AM, Nölling J, Divakar KM, Lin JJ, Carver P, Durkin LM, Hill BT, Smith MR, Radivoyevitch T, Kong LI, Daly T, Murugesan G, Guenther-Johnson J, Dave SS, Manilich EA, Hsi ED

Prognostic impact of the neutrophil-to-lymphocyte ratio in men with metastatic castration-resistant prostate cancer.

Sonpavde G, Pond GR, Armstrong AJ, Clarke SJ, Vardy JL, Templeton AJ, Wang SL, Paolini J, Chen I, Chow-Maneval E, Lechuga M, Smith MR, Michaelson MD

Targeting mTORC1-mediated metabolic addiction overcomes fludarabine resistance in malignant B cells.

Sharma A, Janocha AJ, Hill BT, Smith MR, Erzurum SC, Almasan A

Outcomes of endoscopic human thrombin injection in the management of gastric varices.

Smith MR, Tidswell R, Tripathi D

Frontline bortezomib and rituximab for the treatment of newly diagnosed high tumour burden indolent non-Hodgkin lymphoma: a multicentre phase II study.

Evens AM, Smith MR, Lossos IS, Helenowski I, Millenson M, Winter JN, Rosen ST, Gordon LI

Comparison of the prognostic utility of the revised International Prognostic Scoring System and the French Prognostic Scoring System in azacitidine-treated patients with myelodysplastic syndromes.

Zeidan AM, Lee JW, Prebet T, Greenberg P, Sun Z, Juckett M, Smith MR, Paietta E, Gabrilove J, Erba HP, Tallman MS, Gore SD, Eastern Cooperative Oncology Group (ECOG) and North American Leukemia intergroup

Mycophenolate mofetil therapy in the management of inflammatory bowel disease--a retrospective case series and review.

Smith MR, Cooper SC